Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gamida

Latest From MorphoGen Pharmaceuticals Inc.

Stem Cells--A Proliferating Ambition

Stem cells have applications in organ and tissue repair, gene therapy, drug discovery, and bioartificial organs. Companies are trying to find, grow, and control human embryonic stem cells—totipotent progenitor cells that can give rise to all the tissues in the human body. Investors are intrigued by the opportunity--after all, Sandoz bought 60% of SyStemix at a big premium--but are unnerved by the early-stage of stem cell science, and the all-or-nothing races for patents.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Parent & Subsidiaries
  • Gamida
  • Senior Management
  • Contact Info
  • Gamida
    ,
Advertisement
Advertisement
UsernamePublicRestriction

Register